News
FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...
3h
Zacks Investment Research on MSNRegeneron Initial Data on Multiple Myeloma Drug EncouragingRegeneron Pharmaceuticals, Inc. REGN announced encouraging initial results from two cohorts of the early-stage study on ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.
11h
Zacks Investment Research on MSNPharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & MoreNovo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...
Roche's Itovebi combo gains EMA panel endorsement for advanced breast cancer with PIK3CA mutation. Read more here.
Moderna (MRNA), and Novavax (NVAX) agree as the FDA advisors recommend targeting JN.1 strain for updated COVID vaccines this ...
How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...
The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...
Ireland has pivoted to oppose contentious European Union reforms aimed at broadening access to new drugs and medicines, ...
Leukemia Therapeutics Treatment Market Advancements in leukemia treatments propel global market growth amid rising cancer incidence and R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results